Skip to content

Ticagrelor Related Compound 97

Ticagrelor Related Compound 97

Product Description
CAT No.
ALN-T023107
CAS No.
NA
Mol. F.
C27H32F2N6O9S
Mol. Wt.
654.6
Stock
Please Inquire
Chemical Name : 6-(((1S,2S,3S,4R)-4-(7-(((1R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,3-dihydroxycyclopentyl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid
Smiles : O[C@@H]1[C@@H](OC2OC(C(O)=O)C(O)C(O)C2O)C[C@@H](N3N=NC4=C3N=C(SCCC)N=C4N[C@H]5C(C6=CC=C(F)C(F)=C6)C5)[C@@H]1O
Inchi : InChI=1S/C7H15NO4/c8-4-3-5(12-2-1-9)7(11)6(4)10/h4-7,9-11H,1-3,8H2/t4-,5+,6+,7-/m1/s1

Estimation Of Ticagrelor In Commercial Dosage Form Using A Sensitive Validated RP-HPLC Method

By Madhuri, K.; Rao, Y. Srinivasa; Varaprasada, Rao K.; Deepthi, R.nFrom World Journal of Pharmaceutical Research (2021), 10(6), 1281-1292.

Development and validation of stability indicating RP-HPLC method for the estimation of Ticagrelor by forced degradation studies

By Dole, Manjusha; Kendre, Meenakshi; Wagh, Viplav – From World Journal of Pharmacy and Pharmaceutical Sciences (2019), 8(5), 711-724

Development of a validated HPLC-PDA method for stability indicating study of ticagrelor: a novel anti-platelet agent (P2Y12-ADP receptor blocker)

By Sulthana, Shabana; Anuradha, V.; Rao, Mandava V. Basaveswara – From International Journal of Pharmaceutical, Chemical and Biological Sciences (2017), 7(1), 36-42

Request For Quotation